Related Experiment Video
Updated: Jul 18, 2025

07:08
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
9.6K
Role of aberrant phase separation in pathological protein aggregation
Pijush Chakraborty1, Markus Zweckstetter2
1Department for NMR-based Structural Biology, Max Planck Institute for Multidisciplinary Sciences, Am Faßberg 11, 37077 Göttingen, Germany.
Current Opinion in Structural Biology
|August 21, 2023
Summary
Intrinsically disordered proteins implicated in neurodegenerative diseases can form cellular condensates. These condensates may transition to solid aggregates, contributing to disease pathology.
Area of Science:
- Biochemistry
- Cell Biology
- Neuroscience
Background:
- Neurodegenerative diseases involve the pathological accumulation of intrinsically disordered proteins (IDPs).
- IDPs are increasingly recognized to form dynamic, membrane-less organelles within cells via liquid-liquid phase separation (LLPS).
Purpose of the Study:
- To discuss the role of phase separation in the pathological aggregation of key neuronal proteins linked to neurodegeneration.
- To explore the transition of biomolecular condensates to pathogenic aggregates.
Main Methods:
- Literature review and synthesis of recent evidence on protein phase separation in neurodegeneration.
- Focus on neuronal proteins: tau, alpha-synuclein, fused in sarcoma (FUS), and TDP-43.
Main Results:
- IDPs and proteins with intrinsically disordered regions undergo LLPS to form biomolecular condensates.
- These condensates can mature into pathological species like amyloid fibrils, oligomers, or amorphous aggregates.
- Phase separation is a critical mechanism linking protein dysregulation to neurodegenerative pathologies.
Conclusions:
- The phase separation of neuronal proteins like tau, alpha-synuclein, FUS, and TDP-43 is central to neurodegenerative disease pathogenesis.
- Understanding LLPS and subsequent aggregation is crucial for developing therapeutic strategies against these debilitating conditions.
Related Concept Videos
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Protein Folding
118.4K
Overview
118.4K
Molecular Chaperones and Protein Folding
18.0K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
18.0K
Proteins: From Genes to Degradation
12.3K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
12.3K
The Proteasome
8.8K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.8K
Protein Organization
138.5K
Overview
138.5K

